Learn why St. Luke’s DNA Answers has already completed more than 30,000 genetic screenings to find predisposition for genetic ...

World Prostate Cancer Day encourages individuals to receive regular screenings and research their family history.

Michele Hoaglund, who bought the store about a decade ago from its founding owners, was diagnosed with ovarian cancer around ...

Experts studying the health risks of talc have prompted the U.S. Food and Drug Administration to reevaluate its presence in ...

The legal issues raised by Trump sending the National Guard to L.A. Mystery of America's 'Lost Colony' may finally be solved ...

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

Certain HPV vaccines prevent cancers of the cervix, vulva, vagina, and anus. The time to get vaccinated is between ages 9 and ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.

Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...

Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve ...

Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.